Home Life Edit Therapeutics

Life Edit Therapeutics

acquired
-
Gene Editing Therapy Developer
Basic
Enterprise Profile

Basic Information

Life Edit is a next-generation gene editing company dedicated to paving the way for faster, safer, and more innovative gene editing therapies that can treat diseases once thought incurable. Our platform enables us to target any genomic sequence and develop life-changing therapies for the most challenging genetic disorders.Life Edit boasts the world’s largest and most diverse array of novel RNA-guided nucleases and base editors, which are highly active in mammalian cells. They are developed from a proprietary collection of non-pathogenic organisms and offer gene editing tools with higher fidelity, novel functionalities, reduced risk of immune reactions, and easier delivery. Our genome editing platform stems from AgBiome’s proprietary collection of tens of thousands of microbes.
Life Edit Therapeutics, Inc.
NorthCarolina,United States of America
15~50 people
January 01, 2017
--

Enterprise Profile

Industrial Sector
Scientific Research and Experimental Development Services Gene Therapy
Technology
Biotechnology Gene Editing
Concept
Disease Treatment Rare Diseases
Application Scenarios
Drug Concepts